DA
DVAX

Duality Advisers’s Dynavax Technologies DVAX Stock Holding History

Duality Advisers’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,301
Closed -$227K – 162
2024
Q1 		$227K Buy
+18,301
New +$239K 0.02% 558

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Duality Advisers's DVAX Position: Q2 2024 in Review

Duality Advisers sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 18,301 shares — an estimated $227K sold.

Duality Advisers first reported a position in DVAX in Q1 2024 and held it in 1 quarter. The position peaked at $227K in Q1 2024. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • Duality Advisers reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 18,301 Dynavax Technologies shares in Q2 2024, an estimated $227K.
  • Duality Advisers first reported a position in Dynavax Technologies in Q1 2024 and held it in 1 quarter.
  • Duality Advisers's Dynavax Technologies position peaked at $227K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.